4.5 Article

Neurometabolite Alterations Associated With Cognitive Performance in Perinatally HIV-Infected Children

Journal

MEDICINE
Volume 95, Issue 12, Pages -

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MD.0000000000003093

Keywords

-

Funding

  1. Emma foundation [11.001]
  2. European Commission
  3. Dutch Research Council (ZonMW)
  4. Association of Frontotemporal Dementia/Alzheimer's Drug Discovery Foundation
  5. ISAO
  6. Alzheimer's Drug Discovery Foundation
  7. Novartis
  8. Protagen AG
  9. Swiss MS Society
  10. Biogen
  11. Roche
  12. Genzyme
  13. ECTRIMS Research Fellowship Programme
  14. University of Basel
  15. Swiss National Research Foundation
  16. Bayer (Schweiz) AG
  17. Gilead Sciences
  18. ViiV Healthcare
  19. Janssen Pharmaceutica
  20. Bristol Myers Squibb
  21. Merck Co.

Ask authors/readers for more resources

Despite treatment with combination antiretroviral therapy (cART), cognitive impairment is still observed in perinatally HIV-infected children. We aimed to evaluate potential underlying cerebral injury by comparing neurometabolite levels between perinatally HIV-infected children and healthy controls. This cross-sectional study evaluated neurometabolites, as measured by Magnetic Resonance Spectroscopy (MRS), in perinatally HIV-infected children stable on cART (n = 26) and healthy controls (n = 36). Participants were included from a cohort of perinatally HIV-infected children and healthy controls, matched group-wise for age, gender, ethnicity, and socio-economic status. N-acetylaspartate (NAA), glutamate (Glu), myo-inositol (ml), and choline (Cho) levels were studied as ratios over creatine (Cre). Group differences and associations with HIV-related parameters, cognitive functioning, and neuronal damage markers (neurofilament and total Tau proteins) were determined using age-adjusted linear regression analyses. HIV-infected children had increased Cho:Cre in white matter (HIV-infected = 0.29 +/- 0.03; controls = 0.27 +/- 0.03; P value = 0.045). Lower nadir CD4+ T-cell Z-scores were associated with reduced neuronal integrity markers NAA:Cre and Glu:Cre. A Centers for Disease Control and Prevention (CDC) stage C diagnosis was associated with higher glial markers Cho:Cre and mI:Cre. Poorer cognitive performance was mainly associated with higher Cho:Cre in HIV-infected children, and with lower NAA:Cre and Glu:Cre in healthy controls. There were no associations between neurometabolites and neuronal damage markers in blood or CSF. Compared to controls, perinatally HIV-infected children had increased Cho:Cre in white matter, suggestive of ongoing glial proliferation. Levels of several neurometabolites were associated with cognitive performance, suggesting that MRS may be a useful method to assess cerebral changes potentially linked to cognitive outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available